Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb;22(2):342-346.
doi: 10.1111/jocd.15482. Epub 2022 Oct 31.

Good tolerance of hyaluronic acid filler injections during the COVID-19 pandemic

Michael Naouri  1 , Serge Dahan  2 , Anne Le Pillouer Prost  3 , Phrynée Coutant-Foulc  4 , Catherine Raimbault  5 , Françoise Cucurella  6 , Muriel Creusot  7 , Martine Baspeyras  8 , Martine Darchy  9 , Randa Khallouf  10 , Hugues Cartier  11 , Isabelle Baratte  12 , Magali Dubois  13 , Hans Laubach  14   15 ; Groupe de Dermatologie Esthétique et Correctrice de la Société Française de Dermatologie (GDEC)
Affiliations

Good tolerance of hyaluronic acid filler injections during the COVID-19 pandemic

Michael Naouri et al. J Cosmet Dermatol. 2023 Feb.

Abstract

Background: The aim of our study was to identify and evaluate the complications related to hyaluronic acid during the COVID-19 pandemic.

Method: Twelve dermatologists participated in this study. A cohort and a non-cohort follow-up were ensured.

Results: (1) Cohort follow-up: 1041 patients. 8% had a COVID-19 infection, 27% had received COVID-19 vaccination. 2% had immediate side effects (edema, erythema, bruising). 0.5% had delayed side effects (two inflammatory nodules, one nodule without inflammation, one edema). None of these side effects occurred in the context of infection or COVID-19 vaccinations. (2) Non-cohort follow-up: 7900 syringes used. Two early side effects (inflammatory edema) were reported, of which one occurred 15 days after vaccination. Two cases of delayed side effects such as inflammation on the injected area and inflammatory nodules occurred of which one was in the context of vaccination and one during COVID-19 infection. We estimate the frequency of complications possibly attributable to the disease or to the COVID vaccination to be 0.06% in our population.

Discussion: Complications of HA injections in the context of COVID-19 disease or vaccination appear to be very rare but the frequency could be underestimated because of the low rate of vaccination/infection in our population. Our study shows a very good tolerance of hyaluronic acid injections during the COVID-19 pandemic.

Keywords: COVID-19; coronavirus; filler; hyaluronic acid; immune complication.

PubMed Disclaimer

References

REFERENCES

    1. André P. Evaluation of the safety of a non-animal stabilized hyaluronic acid (NASHA - Q-medical, Sweden) in European countries: a retrospective study from 1997 to 2001. J Eur Acad Dermatol Venereol. 2004;18(4):422-425.
    1. Descamps V, Landry J, Francès C, Marinho E, Ratziu V, Chosidow O. Facial cosmetic filler injections as possible target for systemic sarcoidosis in patients treated with interferon for chronic hepatitis C: two cases. Dermatology. 2008;217(1):81-84.
    1. Naouri M, Dahan S, Le Pillouer PA, et al. Groupe de Dermatologie Esthétique et Correctrice de la Société Française de Dermatologie (GDEC). Good tolerance of hyaluronic acid injections during the period of the COVID-19 pandemic: observing a cohort of 1093 patients in a prospective, observational real-life study. J Eur Acad Dermatol Venereol. 2021;35(7):e432-e433.
    1. Beleznay K, Carruthers JD, Carruthers A, Mummert ME, Humphrey S. Delayed-onset nodules secondary to a smooth cohesive 20 mg/mL hyaluronic acid filler: cause and management. Dermatol Surg. 2015;41(8):929-939.
    1. Humphrey S, Jones DH, Carruthers JD, et al. Retrospective review of delayed adverse events secondary to treatment with a smooth, cohesive 20-mg/mL hyaluronic acid filler in 4500 patients. J Am Acad Dermatol. 2020;83(1):86-95.

MeSH terms

LinkOut - more resources